Skip to main content
Profound Medical Corp. logo

Profound Medical Corp. — Investor Relations & Filings

Ticker · PROF TSX Manufacturing
Open in API
Filings indexed 659 across all filing types
Latest filing 2026-05-14 Regulatory Filings
Country CA Canada
Listing TSX PROF

About Profound Medical Corp.

https://profoundmedical.com/

Profound Medical Corp. is a commercial-stage medical technology company specializing in incision-free ablative therapies. Its core product is TULSA-PRO®, a therapeutic platform designed for the treatment of localized prostate cancer, radiorecurrent prostate cancer, and benign prostatic hyperplasia (BPH). TULSA-PRO utilizes a robotically controlled, transurethral ultrasound ablation procedure guided by real-time Magnetic Resonance (MR) imaging. This system employs closed-loop temperature feedback to ensure precise and customizable tissue ablation, prioritizing patient safety and minimizing complications. The technology merges MR imaging, thermal ultrasound, and robotics to offer a durable and accurate treatment delivery method.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 78% confidence The document is a press release announcing Profound Medical’s upcoming presentations at a medical conference (AUA2026) and marketing its products. It contains no financial statements, no reference to an actual report being published or attached, and is not a transcript, proxy, dividend notice, or other specific filing. It is a general announcement/bulletin and falls into the fallback “Regulatory Filings” category (RNS).
2026-05-14 English
News release - English.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a press release announcing the official vote counts and results from the company’s Annual General and Special Meeting of Shareholders, including director elections and auditor appointment. This matches the definition of Declaration of Voting Results & Voting Rights Announcements.
2026-05-14 English
Report of voting results.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a report of voting results at the annual general and special meeting, detailing vote counts and percentages for director elections, auditor appointment, and plan approval. It cites Section 11.3 of NI 51-102 (Continuous Disclosure Obligations) and provides formal vote outcomes. This matches Declaration of Voting Results & Voting Rights Announcements (Code: DVA).
2026-05-14 English
52-109F2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2026-05-07 English
Interim MD&A - English.pdf
Regulatory Filings
2026-05-07 English
News release - English.pdf
Regulatory Filings
2026-05-07 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.